Positive Causal Link ID'd Between Computer Use, Erectile Dysfunction
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 20, 2024 -- A higher genetic susceptibility to leisure computer usage is associated with an increased risk for erectile dysfunction (ED), according to a study published online March 20 in Andrology.
Zhao Huangfu, from Changhai Hospital in Shanghai, and colleagues explored the causal association between leisure sedentary behavior and ED. Two-sample Mendelian randomization analyses were performed using publicly available genome-wide association studies of leisure sedentary behaviors, erectile dysfunction, sex hormones, biomarkers of endothelial function, and psychiatric symptoms.
The researchers observed a significant association for a greater risk for ED with higher genetic susceptibility to leisure computer usage (odds ratio, 3.57). There was no evidence seen of a link between watching television or driving for leisure and an increased risk for ED. With the exception of follicle-stimulating hormone levels (odds ratio, 0.29), there were no associations between computer use and depression, anxiety, C-reactive protein, E-selectin, matrix metalloproteinase 7, or other sex hormones. In a sensitivity analysis, there was no indication of heterogeneity or pleiotropy.
"The present Mendelian randomization analysis offered substantial evidence for a positive causal association between computer use and risk of ED and found the effect of computer use on follicle-stimulating hormone, which may provide a new research direction for the pathogenesis of ED caused by leisure sedentary behavior," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Lower Alzheimer Risk Seen With PDE5i Initiation for Erectile Dysfunction
WEDNESDAY, Feb. 7, 2024 -- For men with erectile dysfunction (ED), phosphodiesterase type 5 inhibitor (PDE5i) initiation is associated with a lower risk for Alzheimer disease...
Treatment Adverse Events Vary With Favorable, Unfavorable Prognosis in Prostate Cancer
MONDAY, Jan. 29, 2024 -- For patients with localized prostate cancer, the rates of adverse outcomes associated with specific treatments vary for favorable- and...
Combo of PDE5i, Nitrates Increases Cardiovascular Morbidity, Mortality in Stable CAD
TUESDAY, Jan. 16, 2024 -- For men with stable coronary artery disease receiving nitrate medication, the use of phosphodiesterase-5 inhibitor (PDE5i) treatment for erectile...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.